BIIB - Biogen Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 544.04B
Enterprise Value 347.37B
Trailing P/E 8.90
Forward P/E 17.44
PEG Ratio (5 yr expected) 11.61
Price/Sales (ttm)3.13
Price/Book (mrq)3.41
Enterprise Value/Revenue 33.37
Enterprise Value/EBITDA 66.15

Trading Information

Stock Price History

Beta (3Y Monthly) 1.44
52-Week Change 3-32.10%
S&P500 52-Week Change 32.99%
52 Week High 3358.41
52 Week Low 3215.78
50-Day Moving Average 3230.88
200-Day Moving Average 3239.10

Share Statistics

Avg Vol (3 month) 31.46M
Avg Vol (10 day) 31.83M
Shares Outstanding 5184.45M
Float 183.98M
% Held by Insiders 10.47%
% Held by Institutions 193.42%
Shares Short (Aug 15, 2019) 43.93M
Short Ratio (Aug 15, 2019) 42.97
Short % of Float (Aug 15, 2019) 42.03%
Short % of Shares Outstanding (Aug 15, 2019) 42.13%
Shares Short (prior month Jul 15, 2019) 43.79M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/3
Last Split Date 3Jan 18, 2001

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 37.62%
Operating Margin (ttm)50.80%

Management Effectiveness

Return on Assets (ttm)17.78%
Return on Equity (ttm)41.99%

Income Statement

Revenue (ttm)14.07B
Revenue Per Share (ttm)71.43
Quarterly Revenue Growth (yoy)7.80%
Gross Profit (ttm)11.64B
EBITDA 7.7B
Net Income Avi to Common (ttm)5.29B
Diluted EPS (ttm)26.83
Quarterly Earnings Growth (yoy)72.40%

Balance Sheet

Total Cash (mrq)3.12B
Total Cash Per Share (mrq)16.9
Total Debt (mrq)6.44B
Total Debt/Equity (mrq)49.76
Current Ratio (mrq)2.46
Book Value Per Share (mrq)70.09

Cash Flow Statement

Operating Cash Flow (ttm)7.05B
Levered Free Cash Flow (ttm)3.77B